nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextroamphetamine—CYP2D6—breast cancer	0.253	1	CbGaD
Dextroamphetamine—L-Phenylalanine—Melphalan—breast cancer	0.153	0.405	CrCrCtD
Dextroamphetamine—Benzphetamine—Toremifene—breast cancer	0.138	0.365	CrCrCtD
Dextroamphetamine—Benzphetamine—Tamoxifen—breast cancer	0.0867	0.229	CrCrCtD
Dextroamphetamine—CYP2D6—Idarubicin—breast cancer	0.0103	0.414	CbGbCtD
Dextroamphetamine—CYP2D6—Vinorelbine—breast cancer	0.00503	0.202	CbGbCtD
Dextroamphetamine—CYP2D6—Tamoxifen—breast cancer	0.00454	0.183	CbGbCtD
Dextroamphetamine—CYP2D6—Vinblastine—breast cancer	0.0031	0.125	CbGbCtD
Dextroamphetamine—CYP2D6—Doxorubicin—breast cancer	0.00191	0.0766	CbGbCtD
Dextroamphetamine—Pseudoephedrine—IL2—breast cancer	0.000644	0.137	CrCbGaD
Dextroamphetamine—Ephedrine—ACHE—breast cancer	0.000503	0.107	CrCbGaD
Dextroamphetamine—Lacosamide—SCN10A—breast cancer	0.000414	0.0883	CrCbGaD
Dextroamphetamine—Lacosamide—CA9—breast cancer	0.000379	0.0808	CrCbGaD
Dextroamphetamine—Ephedrine—BCHE—breast cancer	0.000296	0.063	CrCbGaD
Dextroamphetamine—Pseudoephedrine—TNF—breast cancer	0.000217	0.0463	CrCbGaD
Dextroamphetamine—Phenformin—CYP2D6—breast cancer	0.00019	0.0404	CrCbGaD
Dextroamphetamine—Benzyl alcohol—CYP1A1—breast cancer	0.000168	0.0358	CrCbGaD
Dextroamphetamine—Nateglinide—PTGS1—breast cancer	0.000158	0.0336	CrCbGaD
Dextroamphetamine—Tranylcypromine—CYP2D6—breast cancer	0.000155	0.033	CrCbGaD
Dextroamphetamine—Abdominal pain upper—Doxorubicin—breast cancer	0.000137	0.000579	CcSEcCtD
Dextroamphetamine—Photosensitivity reaction—Methotrexate—breast cancer	0.000137	0.000577	CcSEcCtD
Dextroamphetamine—Tachycardia—Paclitaxel—breast cancer	0.000136	0.000575	CcSEcCtD
Dextroamphetamine—Urticaria—Mitoxantrone—breast cancer	0.000136	0.000574	CcSEcCtD
Dextroamphetamine—Diarrhoea—Thiotepa—breast cancer	0.000136	0.000572	CcSEcCtD
Dextroamphetamine—Abdominal pain—Irinotecan—breast cancer	0.000135	0.000571	CcSEcCtD
Dextroamphetamine—Body temperature increased—Irinotecan—breast cancer	0.000135	0.000571	CcSEcCtD
Dextroamphetamine—Abdominal pain—Mitoxantrone—breast cancer	0.000135	0.000571	CcSEcCtD
Dextroamphetamine—Body temperature increased—Mitoxantrone—breast cancer	0.000135	0.000571	CcSEcCtD
Dextroamphetamine—Toxic epidermal necrolysis—Doxorubicin—breast cancer	0.000135	0.000571	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Paclitaxel—breast cancer	0.000135	0.000569	CcSEcCtD
Dextroamphetamine—Depression—Methotrexate—breast cancer	0.000133	0.000562	CcSEcCtD
Dextroamphetamine—Anorexia—Paclitaxel—breast cancer	0.000133	0.000561	CcSEcCtD
Dextroamphetamine—Tranylcypromine—CYP3A4—breast cancer	0.000133	0.0283	CrCbGaD
Dextroamphetamine—Stevens-Johnson syndrome—Methotrexate—breast cancer	0.000133	0.000559	CcSEcCtD
Dextroamphetamine—Vomiting—Vinorelbine—breast cancer	0.000132	0.000557	CcSEcCtD
Dextroamphetamine—Body temperature increased—Gemcitabine—breast cancer	0.000132	0.000556	CcSEcCtD
Dextroamphetamine—Tremor—Capecitabine—breast cancer	0.000132	0.000555	CcSEcCtD
Dextroamphetamine—Dizziness—Thiotepa—breast cancer	0.000131	0.000553	CcSEcCtD
Dextroamphetamine—Rash—Vinorelbine—breast cancer	0.000131	0.000552	CcSEcCtD
Dextroamphetamine—Dermatitis—Vinorelbine—breast cancer	0.000131	0.000551	CcSEcCtD
Dextroamphetamine—Urticaria—Fluorouracil—breast cancer	0.00013	0.000549	CcSEcCtD
Dextroamphetamine—Headache—Vinorelbine—breast cancer	0.00013	0.000548	CcSEcCtD
Dextroamphetamine—Phentermine—CYP2D6—breast cancer	0.00013	0.0277	CrCbGaD
Dextroamphetamine—Body temperature increased—Fluorouracil—breast cancer	0.00013	0.000547	CcSEcCtD
Dextroamphetamine—Sweating—Methotrexate—breast cancer	0.000128	0.000541	CcSEcCtD
Dextroamphetamine—Palpitations—Docetaxel—breast cancer	0.000128	0.00054	CcSEcCtD
Dextroamphetamine—Photosensitivity reaction—Epirubicin—breast cancer	0.000128	0.00054	CcSEcCtD
Dextroamphetamine—Weight decreased—Epirubicin—breast cancer	0.000127	0.000536	CcSEcCtD
Dextroamphetamine—Insomnia—Paclitaxel—breast cancer	0.000126	0.000533	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Mitoxantrone—breast cancer	0.000126	0.000532	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Irinotecan—breast cancer	0.000126	0.000532	CcSEcCtD
Dextroamphetamine—Vomiting—Thiotepa—breast cancer	0.000126	0.000532	CcSEcCtD
Dextroamphetamine—Convulsion—Docetaxel—breast cancer	0.000126	0.00053	CcSEcCtD
Dextroamphetamine—Hypertension—Docetaxel—breast cancer	0.000125	0.000528	CcSEcCtD
Dextroamphetamine—Rash—Thiotepa—breast cancer	0.000125	0.000527	CcSEcCtD
Dextroamphetamine—Benzyl alcohol—CYP2D6—breast cancer	0.000125	0.0267	CrCbGaD
Dextroamphetamine—Dermatitis—Thiotepa—breast cancer	0.000125	0.000527	CcSEcCtD
Dextroamphetamine—Dyspnoea—Paclitaxel—breast cancer	0.000125	0.000525	CcSEcCtD
Dextroamphetamine—Headache—Thiotepa—breast cancer	0.000124	0.000524	CcSEcCtD
Dextroamphetamine—Somnolence—Paclitaxel—breast cancer	0.000124	0.000523	CcSEcCtD
Dextroamphetamine—Stevens-Johnson syndrome—Epirubicin—breast cancer	0.000124	0.000523	CcSEcCtD
Dextroamphetamine—Palpitations—Capecitabine—breast cancer	0.000124	0.000523	CcSEcCtD
Dextroamphetamine—Chest pain—Docetaxel—breast cancer	0.000123	0.000521	CcSEcCtD
Dextroamphetamine—Nausea—Vinorelbine—breast cancer	0.000123	0.00052	CcSEcCtD
Dextroamphetamine—Dyspepsia—Paclitaxel—breast cancer	0.000123	0.000518	CcSEcCtD
Dextroamphetamine—Pseudoephedrine—CYP2D6—breast cancer	0.000123	0.0262	CrCbGaD
Dextroamphetamine—Asthenia—Mitoxantrone—breast cancer	0.000123	0.000518	CcSEcCtD
Dextroamphetamine—Asthenia—Irinotecan—breast cancer	0.000123	0.000518	CcSEcCtD
Dextroamphetamine—Urinary tract infection—Epirubicin—breast cancer	0.000122	0.000513	CcSEcCtD
Dextroamphetamine—Decreased appetite—Paclitaxel—breast cancer	0.000121	0.000512	CcSEcCtD
Dextroamphetamine—Hypertension—Capecitabine—breast cancer	0.000121	0.000511	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Fluorouracil—breast cancer	0.000121	0.000509	CcSEcCtD
Dextroamphetamine—Dry mouth—Docetaxel—breast cancer	0.000121	0.000509	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Paclitaxel—breast cancer	0.000121	0.000508	CcSEcCtD
Dextroamphetamine—Fatigue—Paclitaxel—breast cancer	0.00012	0.000508	CcSEcCtD
Dextroamphetamine—Sweating—Epirubicin—breast cancer	0.00012	0.000506	CcSEcCtD
Dextroamphetamine—Selegiline—CYP2D6—breast cancer	0.00012	0.0256	CrCbGaD
Dextroamphetamine—Asthenia—Gemcitabine—breast cancer	0.00012	0.000505	CcSEcCtD
Dextroamphetamine—Chest pain—Capecitabine—breast cancer	0.00012	0.000504	CcSEcCtD
Dextroamphetamine—Constipation—Paclitaxel—breast cancer	0.000119	0.000504	CcSEcCtD
Dextroamphetamine—Anxiety—Capecitabine—breast cancer	0.000119	0.000502	CcSEcCtD
Dextroamphetamine—Photosensitivity reaction—Doxorubicin—breast cancer	0.000119	0.0005	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Docetaxel—breast cancer	0.000118	0.000499	CcSEcCtD
Dextroamphetamine—Nausea—Thiotepa—breast cancer	0.000118	0.000497	CcSEcCtD
Dextroamphetamine—Infection—Docetaxel—breast cancer	0.000118	0.000496	CcSEcCtD
Dextroamphetamine—Weight decreased—Doxorubicin—breast cancer	0.000118	0.000496	CcSEcCtD
Dextroamphetamine—Diarrhoea—Mitoxantrone—breast cancer	0.000117	0.000494	CcSEcCtD
Dextroamphetamine—Diarrhoea—Irinotecan—breast cancer	0.000117	0.000494	CcSEcCtD
Dextroamphetamine—Dry mouth—Capecitabine—breast cancer	0.000117	0.000493	CcSEcCtD
Dextroamphetamine—Tachycardia—Docetaxel—breast cancer	0.000116	0.000487	CcSEcCtD
Dextroamphetamine—Stevens-Johnson syndrome—Doxorubicin—breast cancer	0.000115	0.000484	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Paclitaxel—breast cancer	0.000114	0.000481	CcSEcCtD
Dextroamphetamine—Diarrhoea—Gemcitabine—breast cancer	0.000114	0.000481	CcSEcCtD
Dextroamphetamine—Infection—Capecitabine—breast cancer	0.000114	0.00048	CcSEcCtD
Dextroamphetamine—Erythema multiforme—Methotrexate—breast cancer	0.000114	0.000479	CcSEcCtD
Dextroamphetamine—Dizziness—Irinotecan—breast cancer	0.000113	0.000477	CcSEcCtD
Dextroamphetamine—Anorexia—Docetaxel—breast cancer	0.000113	0.000476	CcSEcCtD
Dextroamphetamine—Urinary tract infection—Doxorubicin—breast cancer	0.000113	0.000475	CcSEcCtD
Dextroamphetamine—Diarrhoea—Fluorouracil—breast cancer	0.000112	0.000473	CcSEcCtD
Dextroamphetamine—Tachycardia—Capecitabine—breast cancer	0.000112	0.000472	CcSEcCtD
Dextroamphetamine—Sweating—Doxorubicin—breast cancer	0.000111	0.000468	CcSEcCtD
Dextroamphetamine—Urticaria—Paclitaxel—breast cancer	0.000111	0.000468	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Capecitabine—breast cancer	0.000111	0.000467	CcSEcCtD
Dextroamphetamine—Body temperature increased—Paclitaxel—breast cancer	0.00011	0.000465	CcSEcCtD
Dextroamphetamine—Abdominal pain—Paclitaxel—breast cancer	0.00011	0.000465	CcSEcCtD
Dextroamphetamine—Anorexia—Capecitabine—breast cancer	0.000109	0.000461	CcSEcCtD
Dextroamphetamine—Vomiting—Mitoxantrone—breast cancer	0.000109	0.000459	CcSEcCtD
Dextroamphetamine—Vomiting—Irinotecan—breast cancer	0.000109	0.000459	CcSEcCtD
Dextroamphetamine—Dizziness—Fluorouracil—breast cancer	0.000108	0.000457	CcSEcCtD
Dextroamphetamine—Rash—Irinotecan—breast cancer	0.000108	0.000455	CcSEcCtD
Dextroamphetamine—Rash—Mitoxantrone—breast cancer	0.000108	0.000455	CcSEcCtD
Dextroamphetamine—Dermatitis—Mitoxantrone—breast cancer	0.000108	0.000455	CcSEcCtD
Dextroamphetamine—Dermatitis—Irinotecan—breast cancer	0.000108	0.000455	CcSEcCtD
Dextroamphetamine—Headache—Irinotecan—breast cancer	0.000107	0.000452	CcSEcCtD
Dextroamphetamine—Headache—Mitoxantrone—breast cancer	0.000107	0.000452	CcSEcCtD
Dextroamphetamine—Nateglinide—CYP2D6—breast cancer	0.000107	0.0229	CrCbGaD
Dextroamphetamine—Benzyl alcohol—CYP3A4—breast cancer	0.000107	0.0229	CrCbGaD
Dextroamphetamine—Insomnia—Docetaxel—breast cancer	0.000107	0.000451	CcSEcCtD
Dextroamphetamine—Erythema multiforme—Epirubicin—breast cancer	0.000106	0.000448	CcSEcCtD
Dextroamphetamine—Vomiting—Gemcitabine—breast cancer	0.000106	0.000447	CcSEcCtD
Dextroamphetamine—Dyspnoea—Docetaxel—breast cancer	0.000106	0.000445	CcSEcCtD
Dextroamphetamine—Somnolence—Docetaxel—breast cancer	0.000105	0.000444	CcSEcCtD
Dextroamphetamine—Rash—Gemcitabine—breast cancer	0.000105	0.000443	CcSEcCtD
Dextroamphetamine—Dermatitis—Gemcitabine—breast cancer	0.000105	0.000443	CcSEcCtD
Dextroamphetamine—Headache—Gemcitabine—breast cancer	0.000105	0.000441	CcSEcCtD
Dextroamphetamine—Vomiting—Fluorouracil—breast cancer	0.000104	0.00044	CcSEcCtD
Dextroamphetamine—Dyspepsia—Docetaxel—breast cancer	0.000104	0.000439	CcSEcCtD
Dextroamphetamine—Insomnia—Capecitabine—breast cancer	0.000104	0.000437	CcSEcCtD
Dextroamphetamine—Rash—Fluorouracil—breast cancer	0.000103	0.000436	CcSEcCtD
Dextroamphetamine—Dermatitis—Fluorouracil—breast cancer	0.000103	0.000436	CcSEcCtD
Dextroamphetamine—Decreased appetite—Docetaxel—breast cancer	0.000103	0.000434	CcSEcCtD
Dextroamphetamine—Selegiline—CYP3A4—breast cancer	0.000103	0.0219	CrCbGaD
Dextroamphetamine—Hypersensitivity—Paclitaxel—breast cancer	0.000103	0.000434	CcSEcCtD
Dextroamphetamine—Headache—Fluorouracil—breast cancer	0.000103	0.000433	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Docetaxel—breast cancer	0.000102	0.000431	CcSEcCtD
Dextroamphetamine—Dyspnoea—Capecitabine—breast cancer	0.000102	0.000431	CcSEcCtD
Dextroamphetamine—Fatigue—Docetaxel—breast cancer	0.000102	0.00043	CcSEcCtD
Dextroamphetamine—Nausea—Irinotecan—breast cancer	0.000102	0.000429	CcSEcCtD
Dextroamphetamine—Nausea—Mitoxantrone—breast cancer	0.000102	0.000429	CcSEcCtD
Dextroamphetamine—Constipation—Docetaxel—breast cancer	0.000101	0.000427	CcSEcCtD
Dextroamphetamine—Dyspepsia—Capecitabine—breast cancer	0.000101	0.000425	CcSEcCtD
Dextroamphetamine—Asthenia—Paclitaxel—breast cancer	0.0001	0.000422	CcSEcCtD
Dextroamphetamine—Amphetamine—CYP2D6—breast cancer	9.97e-05	0.0213	CrCbGaD
Dextroamphetamine—Decreased appetite—Capecitabine—breast cancer	9.96e-05	0.00042	CcSEcCtD
Dextroamphetamine—Nausea—Gemcitabine—breast cancer	9.91e-05	0.000418	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Capecitabine—breast cancer	9.9e-05	0.000417	CcSEcCtD
Dextroamphetamine—Fatigue—Capecitabine—breast cancer	9.88e-05	0.000417	CcSEcCtD
Dextroamphetamine—Erythema multiforme—Doxorubicin—breast cancer	9.83e-05	0.000415	CcSEcCtD
Dextroamphetamine—Constipation—Capecitabine—breast cancer	9.8e-05	0.000413	CcSEcCtD
Dextroamphetamine—Nausea—Fluorouracil—breast cancer	9.74e-05	0.000411	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Docetaxel—breast cancer	9.68e-05	0.000408	CcSEcCtD
Dextroamphetamine—Tension—Epirubicin—breast cancer	9.6e-05	0.000405	CcSEcCtD
Dextroamphetamine—Diarrhoea—Paclitaxel—breast cancer	9.56e-05	0.000403	CcSEcCtD
Dextroamphetamine—Nervousness—Epirubicin—breast cancer	9.5e-05	0.000401	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Capecitabine—breast cancer	9.37e-05	0.000395	CcSEcCtD
Dextroamphetamine—Abdominal pain—Docetaxel—breast cancer	9.36e-05	0.000395	CcSEcCtD
Dextroamphetamine—Body temperature increased—Docetaxel—breast cancer	9.36e-05	0.000395	CcSEcCtD
Dextroamphetamine—Methamphetamine—CYP2D6—breast cancer	9.24e-05	0.0197	CrCbGaD
Dextroamphetamine—Dizziness—Paclitaxel—breast cancer	9.24e-05	0.000389	CcSEcCtD
Dextroamphetamine—Nateglinide—CYP3A4—breast cancer	9.2e-05	0.0196	CrCbGaD
Dextroamphetamine—Urticaria—Capecitabine—breast cancer	9.11e-05	0.000384	CcSEcCtD
Dextroamphetamine—Phenelzine—CYP3A4—breast cancer	9.07e-05	0.0193	CrCbGaD
Dextroamphetamine—Body temperature increased—Capecitabine—breast cancer	9.06e-05	0.000382	CcSEcCtD
Dextroamphetamine—Abdominal pain—Capecitabine—breast cancer	9.06e-05	0.000382	CcSEcCtD
Dextroamphetamine—Convulsion—Methotrexate—breast cancer	9.06e-05	0.000382	CcSEcCtD
Dextroamphetamine—Agitation—Epirubicin—breast cancer	8.99e-05	0.000379	CcSEcCtD
Dextroamphetamine—Chest pain—Methotrexate—breast cancer	8.9e-05	0.000375	CcSEcCtD
Dextroamphetamine—Tension—Doxorubicin—breast cancer	8.88e-05	0.000375	CcSEcCtD
Dextroamphetamine—Vomiting—Paclitaxel—breast cancer	8.88e-05	0.000374	CcSEcCtD
Dextroamphetamine—Rash—Paclitaxel—breast cancer	8.81e-05	0.000371	CcSEcCtD
Dextroamphetamine—Dermatitis—Paclitaxel—breast cancer	8.8e-05	0.000371	CcSEcCtD
Dextroamphetamine—Nervousness—Doxorubicin—breast cancer	8.79e-05	0.000371	CcSEcCtD
Dextroamphetamine—Headache—Paclitaxel—breast cancer	8.75e-05	0.000369	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Docetaxel—breast cancer	8.72e-05	0.000368	CcSEcCtD
Dextroamphetamine—Palpitations—Epirubicin—breast cancer	8.65e-05	0.000364	CcSEcCtD
Dextroamphetamine—Selegiline—ABCB1—breast cancer	8.57e-05	0.0183	CrCbGaD
Dextroamphetamine—Anaphylactic shock—Methotrexate—breast cancer	8.53e-05	0.00036	CcSEcCtD
Dextroamphetamine—Asthenia—Docetaxel—breast cancer	8.49e-05	0.000358	CcSEcCtD
Dextroamphetamine—Convulsion—Epirubicin—breast cancer	8.48e-05	0.000357	CcSEcCtD
Dextroamphetamine—Infection—Methotrexate—breast cancer	8.48e-05	0.000357	CcSEcCtD
Dextroamphetamine—Hypertension—Epirubicin—breast cancer	8.45e-05	0.000356	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Capecitabine—breast cancer	8.44e-05	0.000356	CcSEcCtD
Dextroamphetamine—Chest pain—Epirubicin—breast cancer	8.33e-05	0.000351	CcSEcCtD
Dextroamphetamine—Agitation—Doxorubicin—breast cancer	8.32e-05	0.000351	CcSEcCtD
Dextroamphetamine—Anxiety—Epirubicin—breast cancer	8.3e-05	0.00035	CcSEcCtD
Dextroamphetamine—Nausea—Paclitaxel—breast cancer	8.3e-05	0.00035	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Methotrexate—breast cancer	8.25e-05	0.000348	CcSEcCtD
Dextroamphetamine—Asthenia—Capecitabine—breast cancer	8.22e-05	0.000347	CcSEcCtD
Dextroamphetamine—Dry mouth—Epirubicin—breast cancer	8.15e-05	0.000343	CcSEcCtD
Dextroamphetamine—Anorexia—Methotrexate—breast cancer	8.13e-05	0.000343	CcSEcCtD
Dextroamphetamine—Diarrhoea—Docetaxel—breast cancer	8.1e-05	0.000341	CcSEcCtD
Dextroamphetamine—Nateglinide—ALB—breast cancer	8.02e-05	0.0171	CrCbGaD
Dextroamphetamine—Palpitations—Doxorubicin—breast cancer	8e-05	0.000337	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Epirubicin—breast cancer	7.98e-05	0.000337	CcSEcCtD
Dextroamphetamine—Infection—Epirubicin—breast cancer	7.93e-05	0.000334	CcSEcCtD
Dextroamphetamine—Benzphetamine—CYP3A4—breast cancer	7.86e-05	0.0168	CrCbGaD
Dextroamphetamine—Convulsion—Doxorubicin—breast cancer	7.84e-05	0.000331	CcSEcCtD
Dextroamphetamine—Diarrhoea—Capecitabine—breast cancer	7.84e-05	0.000331	CcSEcCtD
Dextroamphetamine—Dizziness—Docetaxel—breast cancer	7.83e-05	0.00033	CcSEcCtD
Dextroamphetamine—Hypertension—Doxorubicin—breast cancer	7.82e-05	0.000329	CcSEcCtD
Dextroamphetamine—Tachycardia—Epirubicin—breast cancer	7.79e-05	0.000329	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Epirubicin—breast cancer	7.72e-05	0.000325	CcSEcCtD
Dextroamphetamine—Insomnia—Methotrexate—breast cancer	7.72e-05	0.000325	CcSEcCtD
Dextroamphetamine—Chest pain—Doxorubicin—breast cancer	7.71e-05	0.000325	CcSEcCtD
Dextroamphetamine—Anxiety—Doxorubicin—breast cancer	7.68e-05	0.000324	CcSEcCtD
Dextroamphetamine—Anorexia—Epirubicin—breast cancer	7.61e-05	0.000321	CcSEcCtD
Dextroamphetamine—Dyspnoea—Methotrexate—breast cancer	7.61e-05	0.000321	CcSEcCtD
Dextroamphetamine—Somnolence—Methotrexate—breast cancer	7.59e-05	0.00032	CcSEcCtD
Dextroamphetamine—Dizziness—Capecitabine—breast cancer	7.58e-05	0.00032	CcSEcCtD
Dextroamphetamine—Dry mouth—Doxorubicin—breast cancer	7.54e-05	0.000318	CcSEcCtD
Dextroamphetamine—Vomiting—Docetaxel—breast cancer	7.53e-05	0.000317	CcSEcCtD
Dextroamphetamine—Dyspepsia—Methotrexate—breast cancer	7.51e-05	0.000317	CcSEcCtD
Dextroamphetamine—Rash—Docetaxel—breast cancer	7.46e-05	0.000315	CcSEcCtD
Dextroamphetamine—Dermatitis—Docetaxel—breast cancer	7.46e-05	0.000314	CcSEcCtD
Dextroamphetamine—Decreased appetite—Methotrexate—breast cancer	7.42e-05	0.000313	CcSEcCtD
Dextroamphetamine—Headache—Docetaxel—breast cancer	7.42e-05	0.000313	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Doxorubicin—breast cancer	7.39e-05	0.000311	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Methotrexate—breast cancer	7.37e-05	0.000311	CcSEcCtD
Dextroamphetamine—Fatigue—Methotrexate—breast cancer	7.36e-05	0.00031	CcSEcCtD
Dextroamphetamine—Infection—Doxorubicin—breast cancer	7.34e-05	0.000309	CcSEcCtD
Dextroamphetamine—Vomiting—Capecitabine—breast cancer	7.29e-05	0.000307	CcSEcCtD
Dextroamphetamine—Rash—Capecitabine—breast cancer	7.23e-05	0.000305	CcSEcCtD
Dextroamphetamine—Insomnia—Epirubicin—breast cancer	7.22e-05	0.000304	CcSEcCtD
Dextroamphetamine—Dermatitis—Capecitabine—breast cancer	7.22e-05	0.000304	CcSEcCtD
Dextroamphetamine—Tachycardia—Doxorubicin—breast cancer	7.21e-05	0.000304	CcSEcCtD
Dextroamphetamine—Headache—Capecitabine—breast cancer	7.18e-05	0.000303	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Doxorubicin—breast cancer	7.14e-05	0.000301	CcSEcCtD
Dextroamphetamine—Dyspnoea—Epirubicin—breast cancer	7.12e-05	0.0003	CcSEcCtD
Dextroamphetamine—Somnolence—Epirubicin—breast cancer	7.1e-05	0.000299	CcSEcCtD
Dextroamphetamine—Anorexia—Doxorubicin—breast cancer	7.04e-05	0.000297	CcSEcCtD
Dextroamphetamine—Nausea—Docetaxel—breast cancer	7.03e-05	0.000296	CcSEcCtD
Dextroamphetamine—Dyspepsia—Epirubicin—breast cancer	7.03e-05	0.000296	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Methotrexate—breast cancer	6.98e-05	0.000294	CcSEcCtD
Dextroamphetamine—Decreased appetite—Epirubicin—breast cancer	6.94e-05	0.000293	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Epirubicin—breast cancer	6.89e-05	0.000291	CcSEcCtD
Dextroamphetamine—Fatigue—Epirubicin—breast cancer	6.88e-05	0.00029	CcSEcCtD
Dextroamphetamine—Constipation—Epirubicin—breast cancer	6.83e-05	0.000288	CcSEcCtD
Dextroamphetamine—Nausea—Capecitabine—breast cancer	6.81e-05	0.000287	CcSEcCtD
Dextroamphetamine—Urticaria—Methotrexate—breast cancer	6.78e-05	0.000286	CcSEcCtD
Dextroamphetamine—Body temperature increased—Methotrexate—breast cancer	6.74e-05	0.000284	CcSEcCtD
Dextroamphetamine—Abdominal pain—Methotrexate—breast cancer	6.74e-05	0.000284	CcSEcCtD
Dextroamphetamine—Insomnia—Doxorubicin—breast cancer	6.68e-05	0.000282	CcSEcCtD
Dextroamphetamine—Dyspnoea—Doxorubicin—breast cancer	6.59e-05	0.000278	CcSEcCtD
Dextroamphetamine—Somnolence—Doxorubicin—breast cancer	6.57e-05	0.000277	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Epirubicin—breast cancer	6.53e-05	0.000275	CcSEcCtD
Dextroamphetamine—Dyspepsia—Doxorubicin—breast cancer	6.5e-05	0.000274	CcSEcCtD
Dextroamphetamine—Decreased appetite—Doxorubicin—breast cancer	6.42e-05	0.000271	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Doxorubicin—breast cancer	6.38e-05	0.000269	CcSEcCtD
Dextroamphetamine—Fatigue—Doxorubicin—breast cancer	6.37e-05	0.000269	CcSEcCtD
Dextroamphetamine—Urticaria—Epirubicin—breast cancer	6.34e-05	0.000267	CcSEcCtD
Dextroamphetamine—Constipation—Doxorubicin—breast cancer	6.32e-05	0.000266	CcSEcCtD
Dextroamphetamine—Abdominal pain—Epirubicin—breast cancer	6.31e-05	0.000266	CcSEcCtD
Dextroamphetamine—Body temperature increased—Epirubicin—breast cancer	6.31e-05	0.000266	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Methotrexate—breast cancer	6.29e-05	0.000265	CcSEcCtD
Dextroamphetamine—Asthenia—Methotrexate—breast cancer	6.12e-05	0.000258	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Doxorubicin—breast cancer	6.04e-05	0.000255	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Epirubicin—breast cancer	5.88e-05	0.000248	CcSEcCtD
Dextroamphetamine—Urticaria—Doxorubicin—breast cancer	5.87e-05	0.000247	CcSEcCtD
Dextroamphetamine—Body temperature increased—Doxorubicin—breast cancer	5.84e-05	0.000246	CcSEcCtD
Dextroamphetamine—Abdominal pain—Doxorubicin—breast cancer	5.84e-05	0.000246	CcSEcCtD
Dextroamphetamine—Diarrhoea—Methotrexate—breast cancer	5.84e-05	0.000246	CcSEcCtD
Dextroamphetamine—Asthenia—Epirubicin—breast cancer	5.73e-05	0.000242	CcSEcCtD
Dextroamphetamine—Dizziness—Methotrexate—breast cancer	5.64e-05	0.000238	CcSEcCtD
Dextroamphetamine—Diarrhoea—Epirubicin—breast cancer	5.46e-05	0.00023	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Doxorubicin—breast cancer	5.44e-05	0.000229	CcSEcCtD
Dextroamphetamine—Vomiting—Methotrexate—breast cancer	5.42e-05	0.000229	CcSEcCtD
Dextroamphetamine—Rash—Methotrexate—breast cancer	5.38e-05	0.000227	CcSEcCtD
Dextroamphetamine—Dermatitis—Methotrexate—breast cancer	5.37e-05	0.000227	CcSEcCtD
Dextroamphetamine—Headache—Methotrexate—breast cancer	5.35e-05	0.000225	CcSEcCtD
Dextroamphetamine—Asthenia—Doxorubicin—breast cancer	5.3e-05	0.000223	CcSEcCtD
Dextroamphetamine—Dizziness—Epirubicin—breast cancer	5.28e-05	0.000223	CcSEcCtD
Dextroamphetamine—Vomiting—Epirubicin—breast cancer	5.08e-05	0.000214	CcSEcCtD
Dextroamphetamine—Nausea—Methotrexate—breast cancer	5.07e-05	0.000214	CcSEcCtD
Dextroamphetamine—Diarrhoea—Doxorubicin—breast cancer	5.06e-05	0.000213	CcSEcCtD
Dextroamphetamine—Rash—Epirubicin—breast cancer	5.03e-05	0.000212	CcSEcCtD
Dextroamphetamine—Dermatitis—Epirubicin—breast cancer	5.03e-05	0.000212	CcSEcCtD
Dextroamphetamine—Headache—Epirubicin—breast cancer	5e-05	0.000211	CcSEcCtD
Dextroamphetamine—Dizziness—Doxorubicin—breast cancer	4.89e-05	0.000206	CcSEcCtD
Dextroamphetamine—Nausea—Epirubicin—breast cancer	4.74e-05	0.0002	CcSEcCtD
Dextroamphetamine—Vomiting—Doxorubicin—breast cancer	4.7e-05	0.000198	CcSEcCtD
Dextroamphetamine—Rash—Doxorubicin—breast cancer	4.66e-05	0.000196	CcSEcCtD
Dextroamphetamine—Dermatitis—Doxorubicin—breast cancer	4.65e-05	0.000196	CcSEcCtD
Dextroamphetamine—Headache—Doxorubicin—breast cancer	4.63e-05	0.000195	CcSEcCtD
Dextroamphetamine—Nausea—Doxorubicin—breast cancer	4.39e-05	0.000185	CcSEcCtD
Dextroamphetamine—TAAR1—Signaling Pathways—IL6—breast cancer	1.07e-05	0.000104	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CALCA—breast cancer	1.05e-05	0.000103	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PRL—breast cancer	1.05e-05	0.000103	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—AGTR1—breast cancer	1.05e-05	0.000103	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—RPS6—breast cancer	1.04e-05	0.000102	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—FGF4—breast cancer	1.03e-05	0.000101	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—STK11—breast cancer	1.03e-05	0.000101	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—ADAM10—breast cancer	1.03e-05	0.000101	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CXCL12—breast cancer	1.03e-05	0.000101	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CXCR4—breast cancer	1.03e-05	0.000101	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PLG—breast cancer	1.02e-05	9.99e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PAK1—breast cancer	1.01e-05	9.88e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—AKT2—breast cancer	1.01e-05	9.88e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—FGF10—breast cancer	1.01e-05	9.83e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—DPYD—breast cancer	1e-05	9.81e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—MED12—breast cancer	1e-05	9.81e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TCF7L2—breast cancer	9.93e-06	9.71e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—AKT2—breast cancer	9.89e-06	9.66e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ALDOA—breast cancer	9.88e-06	9.66e-05	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—AKT1—breast cancer	9.84e-06	9.62e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PIK3CG—breast cancer	9.81e-06	9.59e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PIK3CD—breast cancer	9.71e-06	9.49e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PDGFA—breast cancer	9.7e-06	9.48e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—NCOA3—breast cancer	9.59e-06	9.38e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NOTCH2—breast cancer	9.58e-06	9.36e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HSP90AA1—breast cancer	9.58e-06	9.36e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TGFBR2—breast cancer	9.56e-06	9.35e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—SLC2A2—breast cancer	9.52e-06	9.31e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—PIK3CD—breast cancer	9.5e-06	9.29e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—ITPR1—breast cancer	9.41e-06	9.2e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—ERBB4—breast cancer	9.35e-06	9.14e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—STAT5A—breast cancer	9.35e-06	9.14e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MMP3—breast cancer	9.35e-06	9.14e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CPT1A—breast cancer	9.33e-06	9.12e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ABCG2—breast cancer	9.33e-06	9.12e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—MTR—breast cancer	9.33e-06	9.12e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—PIK3CB—breast cancer	9.32e-06	9.11e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PRL—breast cancer	9.31e-06	9.11e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—AGTR1—breast cancer	9.31e-06	9.11e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ADAM10—breast cancer	9.18e-06	8.98e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—STK11—breast cancer	9.18e-06	8.98e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—HPGDS—breast cancer	9.15e-06	8.94e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—HBA1—breast cancer	9.09e-06	8.89e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PLG—breast cancer	9.08e-06	8.87e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—SMAD4—breast cancer	9.05e-06	8.85e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IGF1R—breast cancer	9e-06	8.8e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—AKT2—breast cancer	8.98e-06	8.78e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—CXCL8—breast cancer	8.96e-06	8.76e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—FGF10—breast cancer	8.93e-06	8.73e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GSTT1—breast cancer	8.87e-06	8.68e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ACHE—breast cancer	8.87e-06	8.68e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HES1—breast cancer	8.84e-06	8.64e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PLA2G4A—breast cancer	8.79e-06	8.59e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NCOR1—breast cancer	8.79e-06	8.59e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CSF2—breast cancer	8.69e-06	8.5e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—FGF1—breast cancer	8.69e-06	8.5e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—RAF1—breast cancer	8.67e-06	8.48e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NRG1—breast cancer	8.63e-06	8.43e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PIK3CD—breast cancer	8.63e-06	8.43e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PDGFA—breast cancer	8.62e-06	8.42e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—H2AFX—breast cancer	8.56e-06	8.37e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—IL2—breast cancer	8.56e-06	8.37e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—E2F1—breast cancer	8.5e-06	8.31e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TGFBR2—breast cancer	8.49e-06	8.3e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PIK3CB—breast cancer	8.46e-06	8.28e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CYP17A1—breast cancer	8.4e-06	8.21e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ITPR1—breast cancer	8.36e-06	8.17e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ENO1—breast cancer	8.31e-06	8.13e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PTGS1—breast cancer	8.31e-06	8.13e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ERBB4—breast cancer	8.3e-06	8.12e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—STAT5A—breast cancer	8.3e-06	8.12e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MMP3—breast cancer	8.3e-06	8.12e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—PIK3CB—breast cancer	8.28e-06	8.09e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—SPP1—breast cancer	8.17e-06	7.99e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CXCL8—breast cancer	8.13e-06	7.95e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—ERBB3—breast cancer	8.08e-06	7.9e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—FGFR2—breast cancer	8.07e-06	7.89e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—SMAD4—breast cancer	8.04e-06	7.86e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—NCOA2—breast cancer	8e-06	7.83e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IGF1R—breast cancer	7.99e-06	7.81e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—CXCL8—breast cancer	7.96e-06	7.78e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HES1—breast cancer	7.85e-06	7.68e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PLA2G4A—breast cancer	7.81e-06	7.63e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NCOR1—breast cancer	7.81e-06	7.63e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—IL2—breast cancer	7.77e-06	7.6e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—FASN—breast cancer	7.76e-06	7.59e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TERT—breast cancer	7.74e-06	7.57e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—BCHE—breast cancer	7.73e-06	7.56e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—FGF1—breast cancer	7.72e-06	7.55e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CSF2—breast cancer	7.72e-06	7.55e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—RAF1—breast cancer	7.7e-06	7.53e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NRG1—breast cancer	7.66e-06	7.49e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—SLC5A5—breast cancer	7.64e-06	7.46e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—H2AFX—breast cancer	7.61e-06	7.44e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—IL2—breast cancer	7.6e-06	7.43e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—E2F1—breast cancer	7.55e-06	7.38e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—FGFR1—breast cancer	7.52e-06	7.35e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PIK3CB—breast cancer	7.52e-06	7.35e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HIF1A—breast cancer	7.41e-06	7.24e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—SLC2A1—breast cancer	7.37e-06	7.21e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—NQO1—breast cancer	7.37e-06	7.21e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—SPP1—breast cancer	7.26e-06	7.09e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—LEP—breast cancer	7.23e-06	7.07e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CXCL8—breast cancer	7.22e-06	7.06e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CYP3A4—breast cancer	7.19e-06	7.03e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ERBB3—breast cancer	7.18e-06	7.02e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—FGFR2—breast cancer	7.17e-06	7.01e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CAV1—breast cancer	7.16e-06	7e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—KDR—breast cancer	7.08e-06	6.93e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CYP1B1—breast cancer	7.07e-06	6.91e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—HSP90AA1—breast cancer	6.93e-06	6.78e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—IL2—breast cancer	6.9e-06	6.75e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—ESR1—breast cancer	6.9e-06	6.75e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TERT—breast cancer	6.88e-06	6.73e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—FN1—breast cancer	6.82e-06	6.67e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—NCOA1—breast cancer	6.74e-06	6.59e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NFKBIA—breast cancer	6.74e-06	6.59e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—FGFR1—breast cancer	6.68e-06	6.53e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NOTCH1—breast cancer	6.67e-06	6.52e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—STK11—breast cancer	6.65e-06	6.5e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CYP19A1—breast cancer	6.65e-06	6.5e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HIF1A—breast cancer	6.58e-06	6.43e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PIK3CG—breast cancer	6.53e-06	6.38e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—APC—breast cancer	6.53e-06	6.38e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—KIT—breast cancer	6.53e-06	6.38e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—EGF—breast cancer	6.45e-06	6.31e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—LEP—breast cancer	6.42e-06	6.28e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CAV1—breast cancer	6.36e-06	6.22e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—KDR—breast cancer	6.29e-06	6.15e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—MAPK3—breast cancer	6.25e-06	6.11e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—COMT—breast cancer	6.18e-06	6.04e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GSTP1—breast cancer	6.15e-06	6.01e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—BRAF—breast cancer	6.13e-06	6e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ESR1—breast cancer	6.13e-06	5.99e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—HMOX1—breast cancer	6.07e-06	5.93e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—FN1—breast cancer	6.06e-06	5.92e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ITPR1—breast cancer	6.05e-06	5.92e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NFKBIA—breast cancer	5.98e-06	5.85e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IGF1—breast cancer	5.97e-06	5.84e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—AKT2—breast cancer	5.97e-06	5.84e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—EGFR—breast cancer	5.95e-06	5.81e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NOTCH1—breast cancer	5.93e-06	5.79e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ABCB1—breast cancer	5.82e-06	5.69e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—KIT—breast cancer	5.8e-06	5.67e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PIK3CG—breast cancer	5.8e-06	5.67e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—APC—breast cancer	5.8e-06	5.67e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PIK3CD—breast cancer	5.74e-06	5.61e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—EGF—breast cancer	5.73e-06	5.6e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—TYMS—breast cancer	5.72e-06	5.59e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—PIK3CA—breast cancer	5.68e-06	5.56e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—SERPINE1—breast cancer	5.67e-06	5.55e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GSTM1—breast cancer	5.65e-06	5.53e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PLA2G4A—breast cancer	5.65e-06	5.53e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—NCOR1—breast cancer	5.65e-06	5.53e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—KRAS—breast cancer	5.62e-06	5.49e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—MAPK3—breast cancer	5.55e-06	5.43e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—BRAF—breast cancer	5.45e-06	5.33e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NOS3—breast cancer	5.42e-06	5.3e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GPX1—breast cancer	5.41e-06	5.29e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CYP1A1—breast cancer	5.36e-06	5.24e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ERCC2—breast cancer	5.31e-06	5.2e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IGF1—breast cancer	5.31e-06	5.19e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—AKT2—breast cancer	5.3e-06	5.18e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—EGFR—breast cancer	5.28e-06	5.16e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PIK3CA—breast cancer	5.16e-06	5.04e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MDM2—breast cancer	5.14e-06	5.02e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—RAF1—breast cancer	5.12e-06	5.01e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—RELA—breast cancer	5.1e-06	4.98e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PIK3CD—breast cancer	5.1e-06	4.98e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—ERBB2—breast cancer	5.07e-06	4.95e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—PIK3CA—breast cancer	5.05e-06	4.93e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—SERPINE1—breast cancer	5.04e-06	4.93e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PIK3CB—breast cancer	5e-06	4.89e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MTOR—breast cancer	5e-06	4.89e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—MTHFR—breast cancer	5e-06	4.88e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—KRAS—breast cancer	4.99e-06	4.88e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NOS3—breast cancer	4.81e-06	4.7e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CXCL8—breast cancer	4.8e-06	4.7e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—HRAS—breast cancer	4.77e-06	4.67e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CDKN1B—breast cancer	4.69e-06	4.59e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—AKT1—breast cancer	4.64e-06	4.54e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CAV1—breast cancer	4.61e-06	4.5e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CASP3—breast cancer	4.6e-06	4.5e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IL2—breast cancer	4.59e-06	4.49e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PIK3CA—breast cancer	4.58e-06	4.48e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—IL6—breast cancer	4.57e-06	4.47e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MDM2—breast cancer	4.56e-06	4.46e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—RAF1—breast cancer	4.55e-06	4.45e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—RELA—breast cancer	4.53e-06	4.43e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ERBB2—breast cancer	4.5e-06	4.4e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CCND1—breast cancer	4.48e-06	4.38e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—JUN—breast cancer	4.47e-06	4.37e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PIK3CB—breast cancer	4.44e-06	4.34e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MTOR—breast cancer	4.44e-06	4.34e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CTNNB1—breast cancer	4.43e-06	4.33e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MMP9—breast cancer	4.35e-06	4.25e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CDKN1A—breast cancer	4.33e-06	4.23e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PTEN—breast cancer	4.32e-06	4.22e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CXCL8—breast cancer	4.27e-06	4.17e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—HRAS—breast cancer	4.24e-06	4.15e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MAPK8—breast cancer	4.23e-06	4.13e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—AKT1—breast cancer	4.22e-06	4.12e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PIK3CG—breast cancer	4.2e-06	4.1e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CDKN1B—breast cancer	4.17e-06	4.07e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—AKT1—breast cancer	4.12e-06	4.03e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CASP3—breast cancer	4.08e-06	3.99e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IL2—breast cancer	4.08e-06	3.99e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—IL6—breast cancer	4.06e-06	3.97e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—SRC—breast cancer	4.01e-06	3.92e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CCND1—breast cancer	3.98e-06	3.89e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—JUN—breast cancer	3.97e-06	3.88e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CTNNB1—breast cancer	3.94e-06	3.85e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—VEGFA—breast cancer	3.9e-06	3.82e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—STAT3—breast cancer	3.86e-06	3.78e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MMP9—breast cancer	3.86e-06	3.77e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CDKN1A—breast cancer	3.85e-06	3.76e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PTEN—breast cancer	3.84e-06	3.75e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MAPK8—breast cancer	3.75e-06	3.67e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—AKT1—breast cancer	3.74e-06	3.66e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MAPK3—breast cancer	3.69e-06	3.61e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PIK3CD—breast cancer	3.69e-06	3.61e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ALB—breast cancer	3.64e-06	3.56e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MYC—breast cancer	3.59e-06	3.51e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TGFB1—breast cancer	3.58e-06	3.5e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—SRC—breast cancer	3.56e-06	3.48e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—EGFR—breast cancer	3.51e-06	3.43e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—NOS3—breast cancer	3.48e-06	3.41e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—VEGFA—breast cancer	3.47e-06	3.39e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—STAT3—breast cancer	3.43e-06	3.36e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—KRAS—breast cancer	3.32e-06	3.24e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MAPK3—breast cancer	3.28e-06	3.21e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PIK3CB—breast cancer	3.22e-06	3.14e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MYC—breast cancer	3.19e-06	3.12e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PTGS2—breast cancer	3.19e-06	3.12e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TGFB1—breast cancer	3.18e-06	3.11e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—EGFR—breast cancer	3.12e-06	3.05e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PIK3CA—breast cancer	3.05e-06	2.98e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TP53—breast cancer	2.95e-06	2.88e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—KRAS—breast cancer	2.95e-06	2.88e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HRAS—breast cancer	2.82e-06	2.76e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PTEN—breast cancer	2.78e-06	2.72e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PIK3CA—breast cancer	2.71e-06	2.65e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IL6—breast cancer	2.7e-06	2.64e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TP53—breast cancer	2.62e-06	2.56e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HRAS—breast cancer	2.5e-06	2.45e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—AKT1—breast cancer	2.49e-06	2.43e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IL6—breast cancer	2.4e-06	2.34e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—AKT1—breast cancer	2.21e-06	2.16e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PIK3CA—breast cancer	1.96e-06	1.92e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—AKT1—breast cancer	1.6e-06	1.57e-05	CbGpPWpGaD
